Baijin Life Science Holdings Limited (HKG:1466)

HKG:1466 Ratios and Metrics

Market cap in millions HKD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 6, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	503	488	442	454	39	33
Market Cap Growth	20.68%	10.50%	-2.73%	1063.93%	17.12%	-48.57%
Enterprise Value	548	529	403	441	44	50
Last Close Price	0.54	0.69	0.65	0.71	0.12	0.12
PE Ratio	53.90	-	-	52.32	-	-
PS Ratio	4.20	3.60	8.23	5.22	0.62	0.77
PB Ratio	3.19	3.13	3.91	5.80	1.09	0.73
P/TBV Ratio	4.69	4.65	10.88	5.80	1.09	0.73
P/FCF Ratio	-	-	-	-	36.69	-
P/OCF Ratio	-	-	-	-	35.16	-
EV/Sales Ratio	4.57	3.91	7.51	5.08	0.70	1.15
EV/EBITDA Ratio	48.28	29.90	-	-	-	-
EV/EBIT Ratio	108.88	37.69	-	-	-	-
EV/FCF Ratio	-26.56	-	-	-	41.09	-
Debt / Equity Ratio	0.54	0.64	0.45	0.04	0.89	0.69
Debt / EBITDA Ratio	7.53	4.83	-	-	28.25	-
Debt / FCF Ratio	-	-	-	-	29.95	-
Net Debt / Equity Ratio	0.17	0.33	0.11	-0.50	0.21	0.15
Net Debt / EBITDA Ratio	3.12	2.90	-1.41	15.75	-196.54	-0.17
Net Debt / FCF Ratio	-1.33	-1.56	-1.90	1.81	7.21	-0.43
Asset Turnover	0.46	0.56	0.36	0.96	0.72	0.35
Inventory Turnover	1.45	1.63	0.80	2.31	2.12	1.76
Quick Ratio	2.68	2.93	1.68	2.34	1.12	1.41
Current Ratio	4.21	4.57	2.96	4.69	1.75	1.98
Return on Equity (ROE)	3.26%	-0.07%	-8.94%	15.20%	-37.80%	-79.02%
Return on Assets (ROA)	1.21%	3.60%	-4.04%	-1.84%	-0.16%	-21.10%
Return on Invested Capital (ROIC)	2.72%	8.45%	-11.64%	-6.46%	-0.47%	-60.37%
Return on Capital Employed (ROCE)	2.20%	5.80%	-6.10%	-3.40%	-0.60%	-91.40%
Earnings Yield	1.61%	-0.07%	-1.69%	1.91%	-39.65%	-155.52%
FCF Yield	-4.10%	-6.76%	-1.50%	-4.75%	2.73%	-48.67%
Buyback Yield / Dilution	-21.34%	-7.58%	-6.89%	-70.17%	-58.07%	-23.64%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.